

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.05074732 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.05074732 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.81470719 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 6.81470719 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.28552613 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.05050421 |
| 7 | alpha-linolenic acid metabolic process (GO:0036109) | 5.68744879 |
| 8 | tryptophan catabolic process (GO:0006569) | 5.61312124 |
| 9 | indole-containing compound catabolic process (GO:0042436) | 5.61312124 |
| 10 | indolalkylamine catabolic process (GO:0046218) | 5.61312124 |
| 11 | glycosphingolipid catabolic process (GO:0046479) | 5.54091303 |
| 12 | kynurenine metabolic process (GO:0070189) | 5.47584452 |
| 13 | urea cycle (GO:0000050) | 5.46558366 |
| 14 | urea metabolic process (GO:0019627) | 5.46558366 |
| 15 | bile acid biosynthetic process (GO:0006699) | 5.41751246 |
| 16 | glyoxylate metabolic process (GO:0046487) | 5.40124787 |
| 17 | tryptophan metabolic process (GO:0006568) | 5.30383061 |
| 18 | oligosaccharide catabolic process (GO:0009313) | 5.28554532 |
| 19 | cysteine metabolic process (GO:0006534) | 5.24224112 |
| 20 | sulfur amino acid catabolic process (GO:0000098) | 5.17458542 |
| 21 | complement activation, alternative pathway (GO:0006957) | 5.15318445 |
| 22 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.14023287 |
| 23 | high-density lipoprotein particle remodeling (GO:0034375) | 5.08642559 |
| 24 | negative regulation of fibrinolysis (GO:0051918) | 5.07273798 |
| 25 | nitrogen cycle metabolic process (GO:0071941) | 5.02443514 |
| 26 | protein carboxylation (GO:0018214) | 5.00937180 |
| 27 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.00937180 |
| 28 | glycolipid catabolic process (GO:0019377) | 5.00384783 |
| 29 | regulation of protein activation cascade (GO:2000257) | 4.90462277 |
| 30 | serine family amino acid catabolic process (GO:0009071) | 4.88187816 |
| 31 | regulation of fibrinolysis (GO:0051917) | 4.84231426 |
| 32 | regulation of triglyceride catabolic process (GO:0010896) | 4.81118559 |
| 33 | regulation of mononuclear cell migration (GO:0071675) | 4.68340994 |
| 34 | bile acid metabolic process (GO:0008206) | 4.67405156 |
| 35 | lysine metabolic process (GO:0006553) | 4.62357282 |
| 36 | lysine catabolic process (GO:0006554) | 4.62357282 |
| 37 | amino-acid betaine metabolic process (GO:0006577) | 4.62036351 |
| 38 | regulation of complement activation (GO:0030449) | 4.60760921 |
| 39 | homocysteine metabolic process (GO:0050667) | 4.60219557 |
| 40 | aromatic amino acid family metabolic process (GO:0009072) | 4.56980524 |
| 41 | plasma lipoprotein particle clearance (GO:0034381) | 4.56550508 |
| 42 | regulation of cholesterol esterification (GO:0010872) | 4.53890868 |
| 43 | cellular response to thyroid hormone stimulus (GO:0097067) | 4.50855410 |
| 44 | reverse cholesterol transport (GO:0043691) | 4.50502683 |
| 45 | * acylglycerol homeostasis (GO:0055090) | 4.47718661 |
| 46 | * triglyceride homeostasis (GO:0070328) | 4.47718661 |
| 47 | amino sugar catabolic process (GO:0046348) | 4.46885753 |
| 48 | plasma lipoprotein particle remodeling (GO:0034369) | 4.44415735 |
| 49 | protein-lipid complex remodeling (GO:0034368) | 4.44415735 |
| 50 | macromolecular complex remodeling (GO:0034367) | 4.44415735 |
| 51 | ceramide catabolic process (GO:0046514) | 4.43547062 |
| 52 | tyrosine metabolic process (GO:0006570) | 4.40983404 |
| 53 | alpha-amino acid catabolic process (GO:1901606) | 4.36792559 |
| 54 | fat-soluble vitamin biosynthetic process (GO:0042362) | 4.31207051 |
| 55 | phospholipid efflux (GO:0033700) | 4.30519262 |
| 56 | negative regulation of interleukin-12 production (GO:0032695) | 4.28933279 |
| 57 | negative regulation of cholesterol transport (GO:0032375) | 4.16182791 |
| 58 | negative regulation of sterol transport (GO:0032372) | 4.16182791 |
| 59 | cellular ketone body metabolic process (GO:0046950) | 4.13601816 |
| 60 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.10438347 |
| 61 | glutamate metabolic process (GO:0006536) | 4.10423907 |
| 62 | cellular amino acid catabolic process (GO:0009063) | 4.07086728 |
| 63 | coenzyme catabolic process (GO:0009109) | 4.03586174 |
| 64 | glycine metabolic process (GO:0006544) | 4.01672442 |
| 65 | bile acid and bile salt transport (GO:0015721) | 3.97083069 |
| 66 | indolalkylamine metabolic process (GO:0006586) | 3.94678983 |
| 67 | cholesterol efflux (GO:0033344) | 3.94364040 |
| 68 | response to peptidoglycan (GO:0032494) | 3.93005426 |
| 69 | low-density lipoprotein particle clearance (GO:0034383) | 3.92722205 |
| 70 | serine family amino acid metabolic process (GO:0009069) | 3.92245811 |
| 71 | ethanol oxidation (GO:0006069) | 3.86548501 |
| 72 | positive regulation of lipid catabolic process (GO:0050996) | 3.86186618 |
| 73 | * regulation of cholesterol storage (GO:0010885) | 3.82992113 |
| 74 | plasma lipoprotein particle assembly (GO:0034377) | 3.82831438 |
| 75 | cellular modified amino acid catabolic process (GO:0042219) | 3.82650246 |
| 76 | cellular biogenic amine catabolic process (GO:0042402) | 3.82635927 |
| 77 | amine catabolic process (GO:0009310) | 3.82635927 |
| 78 | fatty acid beta-oxidation (GO:0006635) | 3.81870086 |
| 79 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.81587377 |
| 80 | cellular glucuronidation (GO:0052695) | 3.80454462 |
| 81 | membrane lipid catabolic process (GO:0046466) | 3.77426730 |
| 82 | benzene-containing compound metabolic process (GO:0042537) | 3.76818325 |
| 83 | arginine metabolic process (GO:0006525) | 3.76108617 |
| 84 | acetyl-CoA metabolic process (GO:0006084) | 3.75711878 |
| 85 | fatty acid oxidation (GO:0019395) | 3.74146291 |
| 86 | imidazole-containing compound metabolic process (GO:0052803) | 3.72988808 |
| 87 | aldehyde catabolic process (GO:0046185) | 3.72894256 |
| 88 | drug catabolic process (GO:0042737) | 3.72858915 |
| 89 | response to thyroid hormone (GO:0097066) | 3.72580959 |
| 90 | organic acid catabolic process (GO:0016054) | 3.71851316 |
| 91 | carboxylic acid catabolic process (GO:0046395) | 3.71851316 |
| 92 | regulation of macrophage chemotaxis (GO:0010758) | 3.71762907 |
| 93 | sphingolipid catabolic process (GO:0030149) | 3.71407930 |
| 94 | short-chain fatty acid metabolic process (GO:0046459) | 3.70714594 |
| 95 | phospholipid homeostasis (GO:0055091) | 3.69026676 |
| 96 | lipid oxidation (GO:0034440) | 3.67635963 |
| 97 | negative regulation of lipase activity (GO:0060192) | 3.64104208 |
| 98 | carnitine metabolic process (GO:0009437) | 3.63339288 |
| 99 | monocarboxylic acid catabolic process (GO:0072329) | 3.63000146 |
| 100 | fibrinolysis (GO:0042730) | 3.62895168 |
| 101 | cofactor catabolic process (GO:0051187) | 3.62859956 |
| 102 | fatty acid catabolic process (GO:0009062) | 3.62719378 |
| 103 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.61731241 |
| 104 | serine family amino acid biosynthetic process (GO:0009070) | 3.60844423 |
| 105 | * cholesterol homeostasis (GO:0042632) | 3.60050260 |
| 106 | 2-oxoglutarate metabolic process (GO:0006103) | 3.59805948 |
| 107 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.59154129 |
| 108 | neutrophil activation involved in immune response (GO:0002283) | 3.59063443 |
| 109 | valine metabolic process (GO:0006573) | 3.58937192 |
| 110 | low-density lipoprotein particle remodeling (GO:0034374) | 3.58904026 |
| 111 | immunoglobulin mediated immune response (GO:0016064) | 3.58848016 |
| 112 | ketone body metabolic process (GO:1902224) | 3.55373121 |
| 113 | * sterol homeostasis (GO:0055092) | 3.54539835 |
| 114 | complement activation, classical pathway (GO:0006958) | 3.54126987 |
| 115 | complement activation (GO:0006956) | 3.53894847 |
| 116 | blood coagulation, intrinsic pathway (GO:0007597) | 3.49986917 |
| 117 | * positive regulation of triglyceride lipase activity (GO:0061365) | 3.48847675 |
| 118 | * positive regulation of lipoprotein lipase activity (GO:0051006) | 3.48847675 |
| 119 | protein activation cascade (GO:0072376) | 3.48500865 |
| 120 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.42287208 |
| 121 | barbed-end actin filament capping (GO:0051016) | 3.41251335 |
| 122 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.37839776 |
| 123 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.33562295 |
| 124 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.32459871 |
| 125 | myeloid dendritic cell differentiation (GO:0043011) | 3.32205850 |
| 126 | T-helper 1 type immune response (GO:0042088) | 3.32169246 |
| 127 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.29227948 |
| 128 | angiotensin maturation (GO:0002003) | 3.22262352 |
| 129 | eosinophil chemotaxis (GO:0048245) | 3.20139802 |
| 130 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.18608954 |
| 131 | positive regulation of antigen processing and presentation (GO:0002579) | 3.18162079 |
| 132 | N-acetylneuraminate metabolic process (GO:0006054) | 3.17320177 |
| 133 | regulation of vitamin metabolic process (GO:0030656) | 3.08570720 |
| 134 | virion attachment to host cell (GO:0019062) | 3.06403107 |
| 135 | adhesion of symbiont to host cell (GO:0044650) | 3.06403107 |
| 136 | NIK/NF-kappaB signaling (GO:0038061) | 3.05862694 |
| 137 | monocyte chemotaxis (GO:0002548) | 3.04724292 |
| 138 | regulation of podosome assembly (GO:0071801) | 3.02199867 |
| 139 | macrophage activation involved in immune response (GO:0002281) | 3.01747575 |
| 140 | myeloid dendritic cell activation (GO:0001773) | 2.93943750 |
| 141 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.91980185 |
| 142 | regulation of antigen processing and presentation (GO:0002577) | 2.88318175 |
| 143 | macrophage differentiation (GO:0030225) | 2.83927002 |
| 144 | eosinophil migration (GO:0072677) | 2.83312840 |
| 145 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.82481934 |
| 146 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.82396083 |
| 147 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.82325134 |
| 148 | regulation of superoxide anion generation (GO:0032928) | 2.81406937 |
| 149 | adhesion of symbiont to host (GO:0044406) | 2.80676183 |
| 150 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.79261780 |
| 151 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.79121877 |
| 152 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.78733267 |
| 153 | cellular response to cadmium ion (GO:0071276) | 2.78352912 |
| 154 | pinocytosis (GO:0006907) | 2.77797681 |
| 155 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.76321431 |
| 156 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.75799615 |
| 157 | regulation of monocyte chemotaxis (GO:0090025) | 2.74338556 |
| 158 | dendritic cell differentiation (GO:0097028) | 2.73997787 |
| 159 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.73690654 |
| 160 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.73326977 |
| 161 | detection of molecule of bacterial origin (GO:0032490) | 2.72407790 |
| 162 | lipid storage (GO:0019915) | 2.71205958 |
| 163 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.70845170 |
| 164 | vitamin D metabolic process (GO:0042359) | 2.69746294 |
| 165 | positive regulation of lipid storage (GO:0010884) | 2.69234340 |
| 166 | * positive regulation of cholesterol efflux (GO:0010875) | 2.63218366 |
| 167 | regulation of mast cell degranulation (GO:0043304) | 2.62003460 |
| 168 | positive regulation of macrophage derived foam cell differentiation (GO:0010744) | 2.60598891 |
| 169 | keratan sulfate catabolic process (GO:0042340) | 2.60456478 |
| 170 | cellular response to zinc ion (GO:0071294) | 2.59872240 |
| 171 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.59865236 |
| 172 | phagosome maturation (GO:0090382) | 2.56503373 |
| 173 | peptide catabolic process (GO:0043171) | 2.56152116 |
| 174 | positive regulation of leukocyte degranulation (GO:0043302) | 2.53636404 |
| 175 | cellular response to arsenic-containing substance (GO:0071243) | 2.52836207 |
| 176 | regulation of chemokine biosynthetic process (GO:0045073) | 2.51610568 |
| 177 | B cell mediated immunity (GO:0019724) | 2.51334901 |
| 178 | lysosome organization (GO:0007040) | 2.50688731 |
| 179 | lytic vacuole organization (GO:0080171) | 2.50688731 |
| 180 | reactive oxygen species biosynthetic process (GO:1903409) | 2.50020025 |
| 181 | germinal center formation (GO:0002467) | 2.46562026 |
| 182 | protein-lipid complex assembly (GO:0065005) | 2.45194252 |
| 183 | positive regulation of tissue remodeling (GO:0034105) | 2.44767361 |
| 184 | plasma lipoprotein particle organization (GO:0071827) | 2.43263970 |
| 185 | lymphocyte chemotaxis (GO:0048247) | 2.43214348 |
| 186 | granulocyte activation (GO:0036230) | 2.43068214 |
| 187 | regulation of monocyte differentiation (GO:0045655) | 2.42293081 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.89783920 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.82907680 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.31610520 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.18426398 |
| 5 | * PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.15949875 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.03361022 |
| 7 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.74092921 |
| 8 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.07224618 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.79199757 |
| 10 | * CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.63029705 |
| 11 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.60445328 |
| 12 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.26306778 |
| 13 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.22034665 |
| 14 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.16882548 |
| 15 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.15858350 |
| 16 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.08480839 |
| 17 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.1040656 |
| 18 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.98765262 |
| 19 | GATA1_22025678_ChIP-Seq_K562_Human | 1.98722206 |
| 20 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.96654359 |
| 21 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.96461084 |
| 22 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.95647520 |
| 23 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.93072625 |
| 24 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.87809988 |
| 25 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.77259222 |
| 26 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.73108462 |
| 27 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.69750407 |
| 28 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.69104437 |
| 29 | * IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.64646221 |
| 30 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.64055334 |
| 31 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.62720963 |
| 32 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.59371251 |
| 33 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.56825929 |
| 34 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.53509528 |
| 35 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.52620392 |
| 36 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.46950363 |
| 37 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.46365664 |
| 38 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.46278776 |
| 39 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.45946769 |
| 40 | * IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.45323612 |
| 41 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.44671847 |
| 42 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.37253073 |
| 43 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.35510996 |
| 44 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.34620245 |
| 45 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.33725214 |
| 46 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.33284445 |
| 47 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.31591696 |
| 48 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.28727559 |
| 49 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.26774073 |
| 50 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.26437101 |
| 51 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.25730178 |
| 52 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.25041958 |
| 53 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.24479674 |
| 54 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.23659069 |
| 55 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.22515633 |
| 56 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.21339519 |
| 57 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.20831334 |
| 58 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.20319207 |
| 59 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.19574072 |
| 60 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.18757568 |
| 61 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.17884968 |
| 62 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.13462303 |
| 63 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13007041 |
| 64 | MAF_26560356_Chip-Seq_TH1_Human | 1.11367971 |
| 65 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.10257472 |
| 66 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.08190095 |
| 67 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.07730211 |
| 68 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.06821331 |
| 69 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.03467469 |
| 70 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.03068434 |
| 71 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.02428131 |
| 72 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.01049508 |
| 73 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.00541422 |
| 74 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.00003278 |
| 75 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.99820229 |
| 76 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.97070077 |
| 77 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.96950342 |
| 78 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.96345744 |
| 79 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.94436947 |
| 80 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.92800941 |
| 81 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.92766634 |
| 82 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.92432085 |
| 83 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.92182781 |
| 84 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.92018118 |
| 85 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.91172892 |
| 86 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.88939164 |
| 87 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.88512280 |
| 88 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.88278246 |
| 89 | UTX_26944678_Chip-Seq_JUKART_Human | 0.87545900 |
| 90 | MAF_26560356_Chip-Seq_TH2_Human | 0.87245265 |
| 91 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.87179094 |
| 92 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.86548623 |
| 93 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.85674431 |
| 94 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.85144259 |
| 95 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.85109702 |
| 96 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.80877431 |
| 97 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.79835197 |
| 98 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.78286509 |
| 99 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.76346494 |
| 100 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.75211664 |
| 101 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.73957945 |
| 102 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.73242220 |
| 103 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.73242220 |
| 104 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.72712247 |
| 105 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.71539028 |
| 106 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.70894919 |
| 107 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.70599304 |
| 108 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.70441020 |
| 109 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.69623230 |
| 110 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.68835104 |
| 111 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.67485116 |
| 112 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.67475634 |
| 113 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.65800707 |
| 114 | GATA1_19941826_ChIP-Seq_K562_Human | 0.64701829 |
| 115 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.63969332 |
| 116 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.63919159 |
| 117 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.62954813 |
| 118 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.62870485 |
| 119 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.62157305 |
| 120 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.61857357 |
| 121 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.61114861 |
| 122 | GATA2_19941826_ChIP-Seq_K562_Human | 0.61110912 |
| 123 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.60282251 |
| 124 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.58643962 |
| 125 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.58513712 |
| 126 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.57373892 |
| 127 | AR_20517297_ChIP-Seq_VCAP_Human | 0.56899572 |
| 128 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.55036614 |
| 129 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.52890600 |
| 130 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.51952266 |
| 131 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.51668883 |
| 132 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.51335727 |
| 133 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.51188696 |
| 134 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.50538937 |
| 135 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.50283567 |
| 136 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.49905945 |
| 137 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.49230317 |
| 138 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.49037016 |
| 139 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.49015220 |
| 140 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.48816478 |
| 141 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.48046011 |
| 142 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.47731250 |
| 143 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.46552850 |
| 144 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.46333275 |
| 145 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.45826970 |
| 146 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.45648868 |
| 147 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.45269847 |
| 148 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.45201823 |
| 149 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.44396760 |
| 150 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.43930696 |
| 151 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.43075434 |
| 152 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.42427026 |
| 153 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.42147526 |
| 154 | CBP_21632823_ChIP-Seq_H3396_Human | 0.41684203 |
| 155 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.41310424 |
| 156 | * ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.40697632 |
| 157 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.40665130 |
| 158 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.40665130 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * MP0002139_abnormal_hepatobiliary_system | 7.94180482 |
| 2 | MP0005360_urolithiasis | 7.19644021 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.79223635 |
| 4 | * MP0005365_abnormal_bile_salt | 5.77904592 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.73217754 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 3.93952780 |
| 7 | * MP0010329_abnormal_lipoprotein_level | 3.60685208 |
| 8 | MP0003252_abnormal_bile_duct | 3.56914000 |
| 9 | MP0003303_peritoneal_inflammation | 3.35741242 |
| 10 | MP0009840_abnormal_foam_cell | 3.32114861 |
| 11 | MP0002148_abnormal_hypersensitivity_rea | 3.07693857 |
| 12 | MP0005332_abnormal_amino_acid | 2.86133943 |
| 13 | MP0005083_abnormal_biliary_tract | 2.84535596 |
| 14 | MP0003172_abnormal_lysosome_physiology | 2.80675610 |
| 15 | MP0003195_calcinosis | 2.71742760 |
| 16 | MP0000343_altered_response_to | 2.55829224 |
| 17 | MP0001666_abnormal_nutrient_absorption | 2.55642482 |
| 18 | MP0001835_abnormal_antigen_presentation | 2.38731312 |
| 19 | * MP0000609_abnormal_liver_physiology | 2.26260974 |
| 20 | * MP0002118_abnormal_lipid_homeostasis | 2.23402477 |
| 21 | * MP0003191_abnormal_cellular_cholesterol | 2.15352828 |
| 22 | MP0004510_myositis | 2.13587201 |
| 23 | MP0004019_abnormal_vitamin_homeostasis | 2.13462888 |
| 24 | MP0005387_immune_system_phenotype | 2.11969641 |
| 25 | MP0001790_abnormal_immune_system | 2.11969641 |
| 26 | MP0005000_abnormal_immune_tolerance | 2.06333820 |
| 27 | MP0005671_abnormal_response_to | 2.04259194 |
| 28 | MP0002138_abnormal_hepatobiliary_system | 2.02280508 |
| 29 | * MP0005319_abnormal_enzyme/_coenzyme | 1.93031578 |
| 30 | MP0009278_abnormal_bone_marrow | 1.86535523 |
| 31 | MP0001533_abnormal_skeleton_physiology | 1.85167006 |
| 32 | MP0002998_abnormal_bone_remodeling | 1.82645715 |
| 33 | MP0002452_abnormal_antigen_presenting | 1.78664720 |
| 34 | MP0003300_gastrointestinal_ulcer | 1.76288374 |
| 35 | MP0001764_abnormal_homeostasis | 1.72694178 |
| 36 | MP0005397_hematopoietic_system_phenotyp | 1.68176555 |
| 37 | MP0001545_abnormal_hematopoietic_system | 1.68176555 |
| 38 | MP0003868_abnormal_feces_composition | 1.66151356 |
| 39 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.62480058 |
| 40 | MP0005670_abnormal_white_adipose | 1.62105868 |
| 41 | MP0002723_abnormal_immune_serum | 1.61838464 |
| 42 | MP0003186_abnormal_redox_activity | 1.55049778 |
| 43 | MP0001800_abnormal_humoral_immune | 1.49830697 |
| 44 | MP0009643_abnormal_urine_homeostasis | 1.45730806 |
| 45 | MP0010155_abnormal_intestine_physiology | 1.45126304 |
| 46 | MP0005310_abnormal_salivary_gland | 1.43196987 |
| 47 | MP0005451_abnormal_body_composition | 1.41433356 |
| 48 | MP0003448_altered_tumor_morphology | 1.40203448 |
| 49 | MP0003453_abnormal_keratinocyte_physiol | 1.36848300 |
| 50 | MP0002405_respiratory_system_inflammati | 1.36294111 |
| 51 | MP0001819_abnormal_immune_cell | 1.35687504 |
| 52 | MP0002420_abnormal_adaptive_immunity | 1.35372265 |
| 53 | MP0004947_skin_inflammation | 1.33898878 |
| 54 | MP0000858_altered_metastatic_potential | 1.31476279 |
| 55 | MP0009697_abnormal_copulation | 1.29045886 |
| 56 | MP0004130_abnormal_muscle_cell | 1.27753270 |
| 57 | MP0003656_abnormal_erythrocyte_physiolo | 1.25479855 |
| 58 | MP0003705_abnormal_hypodermis_morpholog | 1.24085904 |
| 59 | MP0003011_delayed_dark_adaptation | 1.22393290 |
| 60 | * MP0000598_abnormal_liver_morphology | 1.17628458 |
| 61 | MP0006054_spinal_hemorrhage | 1.17114560 |
| 62 | MP0009333_abnormal_splenocyte_physiolog | 1.16435993 |
| 63 | MP0009764_decreased_sensitivity_to | 1.10995464 |
| 64 | MP0002876_abnormal_thyroid_physiology | 1.10149938 |
| 65 | * MP0008469_abnormal_protein_level | 1.08737182 |
| 66 | MP0005636_abnormal_mineral_homeostasis | 1.06496481 |
| 67 | MP0002971_abnormal_brown_adipose | 1.06337986 |
| 68 | MP0000920_abnormal_myelination | 1.02874416 |
| 69 | MP0003828_pulmonary_edema | 1.02402339 |
| 70 | * MP0009763_increased_sensitivity_to | 1.02198951 |
| 71 | MP0006036_abnormal_mitochondrial_physio | 1.01704459 |
| 72 | MP0003724_increased_susceptibility_to | 1.00803825 |
| 73 | MP0005666_abnormal_adipose_tissue | 1.00407580 |
| 74 | MP0002254_reproductive_system_inflammat | 0.97657461 |
| 75 | MP0002078_abnormal_glucose_homeostasis | 0.96494149 |
| 76 | * MP0009642_abnormal_blood_homeostasis | 0.94610791 |
| 77 | MP0008260_abnormal_autophagy | 0.94310422 |
| 78 | MP0003183_abnormal_peptide_metabolism | 0.92828537 |
| 79 | MP0005165_increased_susceptibility_to | 0.92749397 |
| 80 | MP0004883_abnormal_blood_vessel | 0.92721882 |
| 81 | MP0005535_abnormal_body_temperature | 0.91590400 |
| 82 | MP0005334_abnormal_fat_pad | 0.91455685 |
| 83 | MP0010368_abnormal_lymphatic_system | 0.88961012 |
| 84 | MP0000716_abnormal_immune_system | 0.88720842 |
| 85 | * MP0000604_amyloidosis | 0.88538147 |
| 86 | MP0005058_abnormal_lysosome_morphology | 0.88003152 |
| 87 | MP0002837_dystrophic_cardiac_calcinosis | 0.86486753 |
| 88 | MP0001661_extended_life_span | 0.83949991 |
| 89 | * MP0005647_abnormal_sex_gland | 0.82985812 |
| 90 | MP0001756_abnormal_urination | 0.82166700 |
| 91 | MP0005084_abnormal_gallbladder_morpholo | 0.82012395 |
| 92 | MP0001853_heart_inflammation | 0.81402101 |
| 93 | MP0003279_aneurysm | 0.80630486 |
| 94 | MP0008004_abnormal_stomach_pH | 0.79875054 |
| 95 | MP0005376_homeostasis/metabolism_phenot | 0.79858900 |
| 96 | MP0003690_abnormal_glial_cell | 0.79410348 |
| 97 | MP0003795_abnormal_bone_structure | 0.78462646 |
| 98 | MP0005390_skeleton_phenotype | 0.78278091 |
| 99 | MP0005257_abnormal_intraocular_pressure | 0.78147466 |
| 100 | * MP0003329_amyloid_beta_deposits | 0.77239848 |
| 101 | MP0005448_abnormal_energy_balance | 0.76985984 |
| 102 | MP0005408_hypopigmentation | 0.74313226 |
| 103 | MP0002933_joint_inflammation | 0.73071269 |
| 104 | MP0001663_abnormal_digestive_system | 0.72877017 |
| 105 | MP0005595_abnormal_vascular_smooth | 0.71429487 |
| 106 | MP0009765_abnormal_xenobiotic_induced | 0.70552301 |
| 107 | MP0002090_abnormal_vision | 0.70389612 |
| 108 | MP0005023_abnormal_wound_healing | 0.70162144 |
| 109 | MP0003634_abnormal_glial_cell | 0.69683315 |
| 110 | MP0004782_abnormal_surfactant_physiolog | 0.67679730 |
| 111 | MP0003436_decreased_susceptibility_to | 0.67370065 |
| 112 | MP0005220_abnormal_exocrine_pancreas | 0.67290236 |
| 113 | MP0002136_abnormal_kidney_physiology | 0.63757286 |
| 114 | MP0005464_abnormal_platelet_physiology | 0.63531167 |
| 115 | MP0005266_abnormal_metabolism | 0.63196091 |
| 116 | MP0004185_abnormal_adipocyte_glucose | 0.61432688 |
| 117 | MP0009115_abnormal_fat_cell | 0.61354396 |
| 118 | MP0006035_abnormal_mitochondrial_morpho | 0.58091501 |
| 119 | MP0003075_altered_response_to | 0.55239373 |
| 120 | MP0005375_adipose_tissue_phenotype | 0.51174402 |
| 121 | MP0005167_abnormal_blood-brain_barrier | 0.51088538 |
| 122 | MP0002970_abnormal_white_adipose | 0.49555083 |
| 123 | * MP0003953_abnormal_hormone_level | 0.48163642 |
| 124 | MP0008873_increased_physiological_sensi | 0.47054594 |
| 125 | MP0000639_abnormal_adrenal_gland | 0.46958571 |
| 126 | MP0005395_other_phenotype | 0.46769020 |
| 127 | * MP0001845_abnormal_inflammatory_respons | 0.45309822 |
| 128 | MP0006082_CNS_inflammation | 0.43462945 |
| 129 | MP0005166_decreased_susceptibility_to | 0.43087866 |
| 130 | MP0000230_abnormal_systemic_arterial | 0.42483433 |
| 131 | MP0003638_abnormal_response/metabolism_ | 0.41013443 |
| 132 | * MP0000249_abnormal_blood_vessel | 0.40352252 |
| 133 | MP0000685_abnormal_immune_system | 0.39074893 |
| 134 | MP0002168_other_aberrant_phenotype | 0.38904184 |
| 135 | MP0004043_abnormal_pH_regulation | 0.38862816 |
| 136 | MP0002928_abnormal_bile_duct | 0.37000996 |
| 137 | MP0002796_impaired_skin_barrier | 0.36873668 |
| 138 | MP0001881_abnormal_mammary_gland | 0.36494991 |
| 139 | MP0009053_abnormal_anal_canal | 0.35438637 |
| 140 | MP0008874_decreased_physiological_sensi | 0.34938986 |
| 141 | MP0005164_abnormal_response_to | 0.34850004 |
| 142 | MP0002419_abnormal_innate_immunity | 0.32808074 |
| 143 | MP0009785_altered_susceptibility_to | 0.32073960 |
| 144 | MP0003959_abnormal_lean_body | 0.32063654 |
| 145 | MP0003718_maternal_effect | 0.31926580 |
| 146 | MP0009672_abnormal_birth_weight | 0.31891282 |
| 147 | MP0002135_abnormal_kidney_morphology | 0.30082443 |
| 148 | * MP0005025_abnormal_response_to | 0.29906313 |
| 149 | MP0001765_abnormal_ion_homeostasis | 0.29286031 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of liposaccharide metabolism (HP:0010968) | 8.34867567 |
| 2 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 8.34867567 |
| 3 | Abnormality of glycolipid metabolism (HP:0010969) | 8.34867567 |
| 4 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.74952174 |
| 5 | Deep venous thrombosis (HP:0002625) | 6.53022241 |
| 6 | Intrahepatic cholestasis (HP:0001406) | 6.33294206 |
| 7 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.96251407 |
| 8 | Xanthomatosis (HP:0000991) | 5.89980586 |
| 9 | Prolonged partial thromboplastin time (HP:0003645) | 5.83311423 |
| 10 | Hypobetalipoproteinemia (HP:0003563) | 5.61148161 |
| 11 | Vacuolated lymphocytes (HP:0001922) | 5.37440887 |
| 12 | Complement deficiency (HP:0004431) | 5.33086614 |
| 13 | Increased cerebral lipofuscin (HP:0011813) | 5.29970324 |
| 14 | Hyperlipoproteinemia (HP:0010980) | 5.20707209 |
| 15 | Dysostosis multiplex (HP:0000943) | 4.73191295 |
| 16 | Hyperglycinuria (HP:0003108) | 4.61950551 |
| 17 | Hyperammonemia (HP:0001987) | 4.49452337 |
| 18 | Joint hemorrhage (HP:0005261) | 4.46385623 |
| 19 | Hyperglycinemia (HP:0002154) | 4.44406291 |
| 20 | Abnormality of macrophages (HP:0004311) | 4.39366745 |
| 21 | Hypolipoproteinemia (HP:0010981) | 4.38115020 |
| 22 | Loss of speech (HP:0002371) | 4.37530288 |
| 23 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.35898882 |
| 24 | Ketosis (HP:0001946) | 4.31583596 |
| 25 | Abnormality of glycine metabolism (HP:0010895) | 4.31348716 |
| 26 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.31348716 |
| 27 | Abnormality of the common coagulation pathway (HP:0010990) | 4.28801983 |
| 28 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.16479988 |
| 29 | Epidermoid cyst (HP:0200040) | 4.15602669 |
| 30 | Disinhibition (HP:0000734) | 4.10553243 |
| 31 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.09315829 |
| 32 | Hypoglycemic coma (HP:0001325) | 4.05491149 |
| 33 | Hypoalphalipoproteinemia (HP:0003233) | 3.98044816 |
| 34 | Abnormality of complement system (HP:0005339) | 3.89860032 |
| 35 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.88966434 |
| 36 | Abnormality of the intrinsic pathway (HP:0010989) | 3.82094610 |
| 37 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.81625143 |
| 38 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.80928956 |
| 39 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.79921447 |
| 40 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.79921447 |
| 41 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.79921447 |
| 42 | Mutism (HP:0002300) | 3.76275594 |
| 43 | Axonal loss (HP:0003447) | 3.73070564 |
| 44 | Abnormality of methionine metabolism (HP:0010901) | 3.72095292 |
| 45 | Fat malabsorption (HP:0002630) | 3.69700436 |
| 46 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.64239156 |
| 47 | Eczematoid dermatitis (HP:0000976) | 3.63461036 |
| 48 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.62366273 |
| 49 | Mucopolysacchariduria (HP:0008155) | 3.62366273 |
| 50 | Neurofibrillary tangles (HP:0002185) | 3.59228886 |
| 51 | Recurrent bacterial skin infections (HP:0005406) | 3.49248100 |
| 52 | Recurrent abscess formation (HP:0002722) | 3.47574734 |
| 53 | Hypercholesterolemia (HP:0003124) | 3.47093728 |
| 54 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.33413667 |
| 55 | Ketoacidosis (HP:0001993) | 3.30687233 |
| 56 | Systemic lupus erythematosus (HP:0002725) | 3.19047613 |
| 57 | Autoimmune thrombocytopenia (HP:0001973) | 3.16038189 |
| 58 | Conjugated hyperbilirubinemia (HP:0002908) | 3.14008885 |
| 59 | Abnormality of nucleobase metabolism (HP:0010932) | 3.09869235 |
| 60 | Nuclear cataract (HP:0100018) | 3.07304286 |
| 61 | Hyperbilirubinemia (HP:0002904) | 3.02229407 |
| 62 | Myocardial infarction (HP:0001658) | 2.98250351 |
| 63 | Abnormality of purine metabolism (HP:0004352) | 2.98097018 |
| 64 | Abnormality of serum amino acid levels (HP:0003112) | 2.97526729 |
| 65 | Purpura (HP:0000979) | 2.96417608 |
| 66 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.92444702 |
| 67 | Dicarboxylic aciduria (HP:0003215) | 2.92444702 |
| 68 | Increased serum ferritin (HP:0003281) | 2.88902157 |
| 69 | Gout (HP:0001997) | 2.85868925 |
| 70 | Delayed CNS myelination (HP:0002188) | 2.81661789 |
| 71 | Metabolic acidosis (HP:0001942) | 2.79694903 |
| 72 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.79532869 |
| 73 | Mediastinal lymphadenopathy (HP:0100721) | 2.78462866 |
| 74 | Steatorrhea (HP:0002570) | 2.78115217 |
| 75 | Metaphyseal irregularity (HP:0003025) | 2.76730258 |
| 76 | Glomerulonephritis (HP:0000099) | 2.74686631 |
| 77 | Hepatocellular carcinoma (HP:0001402) | 2.73848108 |
| 78 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.72737799 |
| 79 | Skin nodule (HP:0200036) | 2.72108907 |
| 80 | Lethargy (HP:0001254) | 2.67741306 |
| 81 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.64809826 |
| 82 | Cerebral inclusion bodies (HP:0100314) | 2.62225012 |
| 83 | Upper motor neuron abnormality (HP:0002127) | 2.60433236 |
| 84 | Apathy (HP:0000741) | 2.60040769 |
| 85 | Spontaneous abortion (HP:0005268) | 2.59522012 |
| 86 | Diminished motivation (HP:0000745) | 2.57421676 |
| 87 | Retinal atrophy (HP:0001105) | 2.56323909 |
| 88 | Hepatosplenomegaly (HP:0001433) | 2.54901658 |
| 89 | Generalized aminoaciduria (HP:0002909) | 2.53709931 |
| 90 | Progressive neurologic deterioration (HP:0002344) | 2.48361979 |
| 91 | Hypoglycemic seizures (HP:0002173) | 2.44644675 |
| 92 | Amyloidosis (HP:0011034) | 2.43104412 |
| 93 | Cerebral edema (HP:0002181) | 2.42868015 |
| 94 | Hypochromic microcytic anemia (HP:0004840) | 2.42395040 |
| 95 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.41507563 |
| 96 | Vascular calcification (HP:0004934) | 2.38292485 |
| 97 | Neuronal loss in central nervous system (HP:0002529) | 2.35369335 |
| 98 | Late onset (HP:0003584) | 2.33991374 |
| 99 | Abnormality of the periventricular white matter (HP:0002518) | 2.33901237 |
| 100 | Pancreatitis (HP:0001733) | 2.32739518 |
| 101 | Irritability (HP:0000737) | 2.31533370 |
| 102 | Agnosia (HP:0010524) | 2.31348378 |
| 103 | Prolonged neonatal jaundice (HP:0006579) | 2.31294028 |
| 104 | Orchitis (HP:0100796) | 2.29556046 |
| 105 | Abnormal gallbladder morphology (HP:0012437) | 2.29240950 |
| 106 | Spastic diplegia (HP:0001264) | 2.27803818 |
| 107 | Cholelithiasis (HP:0001081) | 2.25701146 |
| 108 | Chronic obstructive pulmonary disease (HP:0006510) | 2.23728858 |
| 109 | Obstructive lung disease (HP:0006536) | 2.23728858 |
| 110 | Vomiting (HP:0002013) | 2.23008004 |
| 111 | Esophageal varix (HP:0002040) | 2.21969018 |
| 112 | Myositis (HP:0100614) | 2.21173559 |
| 113 | Mitral stenosis (HP:0001718) | 2.21048083 |
| 114 | Dementia (HP:0000726) | 2.20019130 |
| 115 | Pathologic fracture (HP:0002756) | 2.18427613 |
| 116 | Hydroxyprolinuria (HP:0003080) | 2.17171822 |
| 117 | Abnormality of proline metabolism (HP:0010907) | 2.17171822 |
| 118 | Hemorrhage of the eye (HP:0011885) | 2.16979539 |
| 119 | Malnutrition (HP:0004395) | 2.16910656 |
| 120 | Acanthocytosis (HP:0001927) | 2.14548829 |
| 121 | Neonatal onset (HP:0003623) | 2.14030118 |
| 122 | Petechiae (HP:0000967) | 2.13687527 |
| 123 | Bone pain (HP:0002653) | 2.13408360 |
| 124 | Cardiovascular calcification (HP:0011915) | 2.13250585 |
| 125 | Asymmetric septal hypertrophy (HP:0001670) | 2.11779493 |
| 126 | Menorrhagia (HP:0000132) | 2.10742310 |
| 127 | Abnormality of iron homeostasis (HP:0011031) | 2.09904829 |
| 128 | Inappropriate behavior (HP:0000719) | 2.08350933 |
| 129 | Nausea (HP:0002018) | 2.06200755 |
| 130 | Cholecystitis (HP:0001082) | 2.06077259 |
| 131 | Abnormal gallbladder physiology (HP:0012438) | 2.06077259 |
| 132 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.04876711 |
| 133 | Retrobulbar optic neuritis (HP:0100654) | 2.04691751 |
| 134 | Optic neuritis (HP:0100653) | 2.04691751 |
| 135 | Enlarged kidneys (HP:0000105) | 2.03581224 |
| 136 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.03147004 |
| 137 | Sensorimotor neuropathy (HP:0007141) | 2.03137342 |
| 138 | Peripheral demyelination (HP:0011096) | 2.03108891 |
| 139 | Hyperuricemia (HP:0002149) | 2.02451370 |
| 140 | Increased purine levels (HP:0004368) | 2.02451370 |
| 141 | Gingival bleeding (HP:0000225) | 2.01632309 |
| 142 | Nephritis (HP:0000123) | 1.99965554 |
| 143 | Hypertriglyceridemia (HP:0002155) | 1.99807418 |
| 144 | Opisthotonus (HP:0002179) | 1.99441904 |
| 145 | Abnormal cartilage morphology (HP:0002763) | 1.98985909 |
| 146 | Brushfield spots (HP:0001088) | 1.98031108 |
| 147 | Protuberant abdomen (HP:0001538) | 1.97663748 |
| 148 | Gingivitis (HP:0000230) | 1.97555593 |
| 149 | Proximal tubulopathy (HP:0000114) | 1.97175579 |
| 150 | Cardiomegaly (HP:0001640) | 1.96792763 |
| 151 | Vertebral compression fractures (HP:0002953) | 1.95418256 |
| 152 | Recurrent skin infections (HP:0001581) | 1.95003384 |
| 153 | Thrombophlebitis (HP:0004418) | 1.94097295 |
| 154 | Thoracic kyphosis (HP:0002942) | 1.94018711 |
| 155 | Hematochezia (HP:0002573) | 1.92054438 |
| 156 | Multiple enchondromatosis (HP:0005701) | 1.90137867 |
| 157 | Mesangial abnormality (HP:0001966) | 1.89224511 |
| 158 | Pulmonary infiltrates (HP:0002113) | 1.89037605 |
| 159 | Alkalosis (HP:0001948) | 1.87307784 |
| 160 | Abnormality of the gallbladder (HP:0005264) | 1.86831955 |
| 161 | Thin bony cortex (HP:0002753) | 1.86553433 |
| 162 | Glycosuria (HP:0003076) | 1.86211709 |
| 163 | Abnormality of urine glucose concentration (HP:0011016) | 1.86211709 |
| 164 | Personality changes (HP:0000751) | 1.86030389 |
| 165 | Hyperglycemia (HP:0003074) | 1.85553179 |
| 166 | Elevated hepatic transaminases (HP:0002910) | 1.84476043 |
| 167 | Neoplasm of head and neck (HP:0012288) | 1.82931519 |
| 168 | Esophageal neoplasm (HP:0100751) | 1.82931519 |
| 169 | Conjunctival telangiectasia (HP:0000524) | 1.79591835 |
| 170 | Stomatitis (HP:0010280) | 1.78474490 |
| 171 | J-shaped sella turcica (HP:0002680) | 1.77605459 |
| 172 | Hypophosphatemia (HP:0002148) | 1.76559709 |
| 173 | Interstitial pulmonary disease (HP:0006530) | 1.71391826 |
| 174 | Hemoptysis (HP:0002105) | 1.70295518 |
| 175 | Polyneuropathy (HP:0001271) | 1.70184367 |
| 176 | Basal ganglia calcification (HP:0002135) | 1.68990261 |
| 177 | Premature loss of primary teeth (HP:0006323) | 1.66844617 |
| 178 | Bone cyst (HP:0012062) | 1.63437935 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.74768883 |
| 2 | NME2 | 4.81048819 |
| 3 | ERN1 | 4.54333032 |
| 4 | FGFR4 | 3.95375863 |
| 5 | SIK1 | 3.89289600 |
| 6 | GRK7 | 3.08624063 |
| 7 | DDR2 | 3.03059905 |
| 8 | BLK | 2.80834320 |
| 9 | INSRR | 2.76674325 |
| 10 | TRIB3 | 2.73576324 |
| 11 | MUSK | 2.54478500 |
| 12 | ACVR1B | 2.46904126 |
| 13 | MATK | 2.46596363 |
| 14 | TAOK3 | 2.32507762 |
| 15 | PKN2 | 2.18248889 |
| 16 | FGR | 2.13036481 |
| 17 | RIPK4 | 2.10585328 |
| 18 | MST1R | 2.00503753 |
| 19 | ERBB4 | 1.97599376 |
| 20 | TYK2 | 1.81844282 |
| 21 | PTK6 | 1.77054012 |
| 22 | CAMK1D | 1.71718324 |
| 23 | FLT3 | 1.71695271 |
| 24 | TAOK1 | 1.68075829 |
| 25 | PIM2 | 1.64740296 |
| 26 | IRAK3 | 1.59703518 |
| 27 | IRAK4 | 1.57459979 |
| 28 | MAPK11 | 1.57216206 |
| 29 | RIPK1 | 1.54344392 |
| 30 | CDC42BPA | 1.52818803 |
| 31 | MAP2K4 | 1.51409375 |
| 32 | PIK3CG | 1.46868534 |
| 33 | ADRBK2 | 1.42338435 |
| 34 | NEK9 | 1.42180920 |
| 35 | ABL2 | 1.41278669 |
| 36 | TBK1 | 1.40418610 |
| 37 | FRK | 1.38020920 |
| 38 | PRPF4B | 1.35914646 |
| 39 | MAP2K3 | 1.31122365 |
| 40 | TESK1 | 1.29461288 |
| 41 | TIE1 | 1.28402951 |
| 42 | JAK2 | 1.28092023 |
| 43 | JAK1 | 1.26657392 |
| 44 | DAPK2 | 1.25797760 |
| 45 | PRKAA2 | 1.22520226 |
| 46 | KDR | 1.20602769 |
| 47 | MAP3K14 | 1.16401219 |
| 48 | TESK2 | 1.15809875 |
| 49 | LATS1 | 1.13962193 |
| 50 | MAP3K3 | 1.13234333 |
| 51 | PDK3 | 1.10916574 |
| 52 | PDK4 | 1.10916574 |
| 53 | CAMKK2 | 1.06459372 |
| 54 | TGFBR2 | 1.06292284 |
| 55 | IKBKB | 1.05482525 |
| 56 | PINK1 | 0.99991484 |
| 57 | LYN | 0.93959131 |
| 58 | MAP3K7 | 0.93521911 |
| 59 | MOS | 0.92982661 |
| 60 | CAMK1G | 0.89645968 |
| 61 | CSK | 0.88589581 |
| 62 | MAPK15 | 0.84291864 |
| 63 | MAPK4 | 0.83396512 |
| 64 | PAK4 | 0.83161911 |
| 65 | GRK6 | 0.82872632 |
| 66 | EPHB2 | 0.82138491 |
| 67 | SYK | 0.80077681 |
| 68 | MAP3K11 | 0.79958352 |
| 69 | MET | 0.78304882 |
| 70 | FGFR2 | 0.77222752 |
| 71 | CHUK | 0.77186094 |
| 72 | EPHB1 | 0.77088124 |
| 73 | IKBKE | 0.73227214 |
| 74 | GSK3A | 0.72783273 |
| 75 | FGFR3 | 0.72000023 |
| 76 | FES | 0.71915210 |
| 77 | PRKAA1 | 0.70596369 |
| 78 | PRKACG | 0.70580406 |
| 79 | MAP3K10 | 0.70147814 |
| 80 | TXK | 0.69306008 |
| 81 | PDK2 | 0.68974502 |
| 82 | PDPK1 | 0.66669570 |
| 83 | PRKCZ | 0.66649038 |
| 84 | IRAK2 | 0.65549833 |
| 85 | CSF1R | 0.63822139 |
| 86 | MAPK12 | 0.63151814 |
| 87 | TYRO3 | 0.62481926 |
| 88 | CDK6 | 0.62198180 |
| 89 | LCK | 0.61368285 |
| 90 | RPS6KC1 | 0.61367727 |
| 91 | RPS6KL1 | 0.61367727 |
| 92 | STK38L | 0.59399092 |
| 93 | ERBB2 | 0.58892000 |
| 94 | KIT | 0.57557133 |
| 95 | MAP4K1 | 0.57146146 |
| 96 | EPHA3 | 0.57012367 |
| 97 | MARK3 | 0.55608430 |
| 98 | LIMK1 | 0.55402237 |
| 99 | RPS6KA2 | 0.54764202 |
| 100 | TGFBR1 | 0.52542552 |
| 101 | SGK3 | 0.52141043 |
| 102 | MAP3K13 | 0.52109151 |
| 103 | IGF1R | 0.50450410 |
| 104 | DYRK1B | 0.49162071 |
| 105 | RPS6KA6 | 0.48577644 |
| 106 | HCK | 0.48267171 |
| 107 | MAP2K1 | 0.47195971 |
| 108 | PDK1 | 0.46788790 |
| 109 | CAMK2G | 0.46775507 |
| 110 | BMPR2 | 0.46415509 |
| 111 | TAOK2 | 0.43326933 |
| 112 | JAK3 | 0.43076197 |
| 113 | ARAF | 0.42297780 |
| 114 | MAP2K2 | 0.41574141 |
| 115 | BTK | 0.39915010 |
| 116 | CSNK1G1 | 0.39795532 |
| 117 | PRKCH | 0.38319244 |
| 118 | DAPK3 | 0.37985369 |
| 119 | PTK2 | 0.37750083 |
| 120 | CAMK4 | 0.37590907 |
| 121 | MAP3K5 | 0.37311116 |
| 122 | ZAP70 | 0.36113336 |
| 123 | MYLK | 0.35835687 |
| 124 | CDK4 | 0.35740109 |
| 125 | PDGFRA | 0.35066000 |
| 126 | MAP2K6 | 0.34634036 |
| 127 | MTOR | 0.34241518 |
| 128 | MAPK7 | 0.33656910 |
| 129 | MAP3K1 | 0.33221962 |
| 130 | TTN | 0.31447781 |
| 131 | PRKCQ | 0.31187100 |
| 132 | PBK | 0.30980235 |
| 133 | BMX | 0.30587020 |
| 134 | ICK | 0.30266972 |
| 135 | PRKG2 | 0.29802461 |
| 136 | GRK1 | 0.29701095 |
| 137 | SGK2 | 0.29686269 |
| 138 | PRKCD | 0.28605690 |
| 139 | PIK3CA | 0.28217455 |
| 140 | MAPKAPK2 | 0.28057417 |
| 141 | MAP3K6 | 0.27568297 |
| 142 | RET | 0.27501500 |
| 143 | TNK2 | 0.26847262 |
| 144 | EGFR | 0.26538204 |
| 145 | IRAK1 | 0.26351337 |
| 146 | MAPKAPK3 | 0.25832067 |
| 147 | ABL1 | 0.25512381 |
| 148 | INSR | 0.24362134 |
| 149 | PIM1 | 0.23503047 |
| 150 | PDGFRB | 0.22864269 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Other glycan degradation_Homo sapiens_hsa00511 | 4.24908713 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.20510187 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.48986337 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.15974163 |
| 5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.05117345 |
| 6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.95567656 |
| 7 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.77137149 |
| 8 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.71355677 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.70960432 |
| 10 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.65896458 |
| 11 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.63478178 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.63056010 |
| 13 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.50813243 |
| 14 | Asthma_Homo sapiens_hsa05310 | 2.46100769 |
| 15 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.43199541 |
| 16 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.26467096 |
| 17 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.24604464 |
| 18 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.23730304 |
| 19 | Allograft rejection_Homo sapiens_hsa05330 | 2.20299281 |
| 20 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.17036819 |
| 21 | Peroxisome_Homo sapiens_hsa04146 | 2.15121094 |
| 22 | Leishmaniasis_Homo sapiens_hsa05140 | 2.14496809 |
| 23 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.13819559 |
| 24 | * PPAR signaling pathway_Homo sapiens_hsa03320 | 2.11377224 |
| 25 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.02979229 |
| 26 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.98632595 |
| 27 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.95360747 |
| 28 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.93280589 |
| 29 | Tuberculosis_Homo sapiens_hsa05152 | 1.85843231 |
| 30 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.85443797 |
| 31 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.82430913 |
| 32 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.80496761 |
| 33 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.79967638 |
| 34 | Histidine metabolism_Homo sapiens_hsa00340 | 1.78378264 |
| 35 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.78367364 |
| 36 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.78153304 |
| 37 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.77247417 |
| 38 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.72039423 |
| 39 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.71009541 |
| 40 | Phagosome_Homo sapiens_hsa04145 | 1.69831578 |
| 41 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.63992091 |
| 42 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.59142321 |
| 43 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.56552713 |
| 44 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.55828196 |
| 45 | Malaria_Homo sapiens_hsa05144 | 1.55586801 |
| 46 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.53421093 |
| 47 | Retinol metabolism_Homo sapiens_hsa00830 | 1.52614884 |
| 48 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.52408105 |
| 49 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.50536258 |
| 50 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.49955319 |
| 51 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.47014213 |
| 52 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.45831853 |
| 53 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.45788698 |
| 54 | Bile secretion_Homo sapiens_hsa04976 | 1.41116349 |
| 55 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.39610152 |
| 56 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.38539108 |
| 57 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.38348784 |
| 58 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.38253062 |
| 59 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.34022094 |
| 60 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.33177853 |
| 61 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.32566295 |
| 62 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.31176376 |
| 63 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.28597222 |
| 64 | Carbon metabolism_Homo sapiens_hsa01200 | 1.26701973 |
| 65 | Legionellosis_Homo sapiens_hsa05134 | 1.26485731 |
| 66 | ABC transporters_Homo sapiens_hsa02010 | 1.25711435 |
| 67 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.19198054 |
| 68 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.19075591 |
| 69 | Salmonella infection_Homo sapiens_hsa05132 | 1.18968547 |
| 70 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.17827309 |
| 71 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.16544570 |
| 72 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.08818357 |
| 73 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.06530427 |
| 74 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.04885876 |
| 75 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.04495295 |
| 76 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.04304125 |
| 77 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.02725932 |
| 78 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.02174299 |
| 79 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.99922396 |
| 80 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.99891440 |
| 81 | Influenza A_Homo sapiens_hsa05164 | 0.96217444 |
| 82 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.95986576 |
| 83 | Viral myocarditis_Homo sapiens_hsa05416 | 0.95397359 |
| 84 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.93796514 |
| 85 | Sulfur relay system_Homo sapiens_hsa04122 | 0.93675888 |
| 86 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.93607371 |
| 87 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.93087535 |
| 88 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.92182159 |
| 89 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.91485399 |
| 90 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.90158588 |
| 91 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.90068623 |
| 92 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.89733316 |
| 93 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.87447701 |
| 94 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.84333672 |
| 95 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.82945286 |
| 96 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.77448980 |
| 97 | Lysine degradation_Homo sapiens_hsa00310 | 0.77259866 |
| 98 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.74441676 |
| 99 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.72978277 |
| 100 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.68093442 |
| 101 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.68074448 |
| 102 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.66674032 |
| 103 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.65181912 |
| 104 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.61788686 |
| 105 | Bladder cancer_Homo sapiens_hsa05219 | 0.61112549 |
| 106 | Shigellosis_Homo sapiens_hsa05131 | 0.55623683 |
| 107 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.54535695 |
| 108 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.53709270 |
| 109 | Apoptosis_Homo sapiens_hsa04210 | 0.48975130 |
| 110 | Metabolic pathways_Homo sapiens_hsa01100 | 0.47033340 |
| 111 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.43698467 |
| 112 | Prion diseases_Homo sapiens_hsa05020 | 0.37763744 |
| 113 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.37292065 |
| 114 | Galactose metabolism_Homo sapiens_hsa00052 | 0.36589452 |
| 115 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.36335348 |
| 116 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.35217152 |
| 117 | Measles_Homo sapiens_hsa05162 | 0.34747627 |
| 118 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.34672651 |
| 119 | * Insulin resistance_Homo sapiens_hsa04931 | 0.33384264 |
| 120 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.28589942 |
| 121 | Hepatitis B_Homo sapiens_hsa05161 | 0.28148286 |
| 122 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.26508026 |
| 123 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.25591309 |
| 124 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.25044046 |
| 125 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.18352494 |
| 126 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.14214439 |
| 127 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.13286785 |
| 128 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.06505928 |
| 129 | * Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.05615101 |
| 130 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.03782891 |
| 131 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.01154715 |
| 132 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.1758247 |
| 133 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.1704109 |
| 134 | Amoebiasis_Homo sapiens_hsa05146 | -0.1674551 |
| 135 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1665009 |
| 136 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | -0.1639020 |
| 137 | * Hepatitis C_Homo sapiens_hsa05160 | -0.1551145 |
| 138 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1361367 |
| 139 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1334682 |
| 140 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1322004 |
| 141 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1294459 |
| 142 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1285622 |
| 143 | Mineral absorption_Homo sapiens_hsa04978 | -0.1204134 |
| 144 | Pertussis_Homo sapiens_hsa05133 | -0.1104145 |
| 145 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0889569 |
| 146 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0782197 |
| 147 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.0525810 |
| 148 | Lysosome_Homo sapiens_hsa04142 | -0.0439908 |
| 149 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0159892 |

